Ovarian protection with gonadotropin-releasing hormone agonists during cyclophosphamide therapy in systemic lupus erythematosus

Best Practice & Research Clinical Obstetrics & Gynaecology ◽

10.1016/j.bpobgyn.2019.10.008 ◽

2020 ◽

Vol 64 ◽

pp. 97-106 ◽

Author(s):

Ruba Kado ◽

W. Joseph McCune

Keyword(s):

Systemic Lupus Erythematosus ◽

Lupus Erythematosus ◽

Gonadotropin Releasing Hormone ◽

Systemic Lupus ◽

Releasing Hormone ◽

Cyclophosphamide Therapy ◽

Ovarian Protection

Download Full-text

SHOULD GONADOTROPIN RELEASING HORMONE ANALOGUE BE ADMINISTERED TO PREVENT PREMATURE OVARIAN FAILURE IN YOUNG WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS ON CYCLOPHOSPHAMIDE THERAPY?

Archives of Disease in Childhood ◽

10.1136/adc.2007.131334 ◽

2008 ◽

Vol 93 (5) ◽

pp. 444-445 ◽

Author(s):

R. Sinha ◽

J. M Dionne

Keyword(s):

Systemic Lupus Erythematosus ◽

Young Women ◽

Premature Ovarian Failure ◽

Lupus Erythematosus ◽

Gonadotropin Releasing Hormone ◽

Systemic Lupus ◽

Hormone Analogue ◽

Releasing Hormone ◽

Cyclophosphamide Therapy ◽

Gonadotropin Releasing Hormone Analogue

Download Full-text

SAT0260 Ovarian function preservation with gonadotropin-releasing hormone analogues in patients with systemic lupus erythematosus treated with cyclophosphamide

10.1136/annrheumdis-2017-eular.6381 ◽

2017 ◽

Author(s):

VA Pacucci ◽

F Ceccarelli ◽

G Perrone ◽

I Zannini ◽

M Candelieri ◽

...

Keyword(s):

Systemic Lupus Erythematosus ◽

Lupus Erythematosus ◽

Ovarian Function ◽

Gonadotropin Releasing Hormone ◽

Systemic Lupus ◽

Releasing Hormone ◽

Function Preservation

Download Full-text

Worsening Of Systemic Lupus Erythematosus-Associated Thrombocytopenia After Administration Of Gonadotropin-Releasing Hormone Analog

Arthritis & Rheumatism ◽

10.1002/art.1780371123 ◽

1994 ◽

Vol 37 (11) ◽

pp. 1708-1709 ◽

Author(s):

Sachikio Miyagawa ◽

Toshihiko Shirai ◽

Ikuko Shimamota ◽

Motolhiko Ichijo ◽

Hiroaki Ueki

Keyword(s):

Systemic Lupus Erythematosus ◽

Lupus Erythematosus ◽

Gonadotropin Releasing Hormone ◽

Systemic Lupus ◽

Releasing Hormone ◽

Download Full-text

Administration of gonadotropin-releasing hormone analog as adjunctive therapy in women systemic lupus erythematosus

Arthritis & Rheumatism ◽

10.1002/anr.1780320924 ◽

1989 ◽

Vol 32 (9) ◽

pp. 1186-1188 ◽

Author(s):

Anna Catania ◽

Ida Mangone ◽

Paola Motta ◽

Carlo Zanussi

Keyword(s):

Systemic Lupus Erythematosus ◽

Lupus Erythematosus ◽

Adjunctive Therapy ◽

Gonadotropin Releasing Hormone ◽

Systemic Lupus ◽

Releasing Hormone ◽

Download Full-text

AB0074 Pulse methylprednisolone and cyclophosphamide therapy in three systemic lupus erythematosus patients with bronchiolitis obliterans organising pneumonia as the initial manifestation

10.1136/annrheumdis-2001.119 ◽

2001 ◽

Author(s):

JC Tseng ◽

HH Cheng ◽

RJ Hu ◽

LY Lu

Keyword(s):

Systemic Lupus Erythematosus ◽

Lupus Erythematosus ◽

Bronchiolitis Obliterans ◽

Systemic Lupus ◽

Initial Manifestation ◽

Pulse Methylprednisolone ◽

Cyclophosphamide Therapy

Download Full-text

Limbic encephalitis in a patient with systemic lupus erythematosus successfully treated with high-dose glucocorticoids and intravenous cyclophosphamide therapy: the potential pathogenicity of anti-glutamate receptor antibodies

Modern Rheumatology Case Reports ◽

10.1080/24725625.2021.1876340 ◽

2021 ◽

pp. 1-6

Author(s):

Haruka Tsuchiya ◽

Yukiko Iwasaki ◽

Hirofumi Shoda ◽

Yukitoshi Takahashi ◽

Keishi Fujio

Keyword(s):

Systemic Lupus Erythematosus ◽

Glutamate Receptor ◽

Lupus Erythematosus ◽

Limbic Encephalitis ◽

High Dose ◽

Systemic Lupus ◽

Intravenous Cyclophosphamide ◽

Cyclophosphamide Therapy ◽

Potential Pathogenicity ◽

Receptor Antibodies

Download Full-text

TREATMENT OF SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS WITH PULSED INTRAVENOUS CYCLOPHOSPHAMIDE THERAPY

Southern Medical Journal ◽

10.1097/00007611-199510001-00040 ◽

1995 ◽

Vol 88 ◽

pp. S27

Author(s):

Margaret E. Parsons ◽

Erin E. Boh

Keyword(s):

Systemic Lupus Erythematosus ◽

Lupus Erythematosus ◽

Systemic Lupus ◽

Intravenous Cyclophosphamide ◽

Cyclophosphamide Therapy ◽

Severe Systemic Lupus Erythematosus

Download Full-text

Severity of systemic lupus erythematosus with diffuse proliferative glomerulonephritis and the ineffectiveness of standard pulse intravenous cyclophosphamide therapy in Jamaican patients

Lupus ◽

10.1191/0961203303lu437xx ◽

2003 ◽

Vol 12 (8) ◽

pp. 640-645 ◽

Author(s):

W Williams ◽

A Bhagwandass ◽

L A Sargeant ◽

D Shah

Keyword(s):

Systemic Lupus Erythematosus ◽

Lupus Erythematosus ◽

Proliferative Glomerulonephritis ◽

Systemic Lupus ◽

Intravenous Cyclophosphamide ◽

Cyclophosphamide Therapy ◽

Standard Pulse ◽

Diffuse Proliferative Glomerulonephritis

Download Full-text

Relationship of glutathione S-transferase genotypes with side-effects of pulsed cyclophosphamide therapy in patients with systemic lupus erythematosus

British Journal of Clinical Pharmacology ◽

10.1111/j.1365-2125.2006.02690.x ◽

2006 ◽

Vol 62 (4) ◽

pp. 457-472 ◽

Author(s):

Shilong Zhong ◽

Min Huang ◽

Xiuyan Yang ◽

Liuqin Liang ◽

Yixi Wang ◽

...

Keyword(s):

Systemic Lupus Erythematosus ◽

Side Effects ◽

Lupus Erythematosus ◽

Glutathione S Transferase ◽

Systemic Lupus ◽

Cyclophosphamide Therapy ◽

Relationship Of

Download Full-text

Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy

Arthritis & Rheumatism ◽

10.1002/1529-0131(199805)41:5<831::aid-art9>3.0.co;2-1 ◽

1998 ◽

Vol 41 (5) ◽

pp. 831-837 ◽

Author(s):

Chi Chiu Mok ◽

Chak Sing Lau ◽

Raymond Woon Sing Wong

Keyword(s):

Risk Factors ◽

Systemic Lupus Erythematosus ◽

Lupus Erythematosus ◽

Ovarian Failure ◽

Systemic Lupus ◽

Cyclophosphamide Therapy

Download Full-text